Michael Rice is CEO & President at BIOLIFE SOLUTIONS INC (BLFS). They have made 89 open-market trades across 1 company since 2014, most recently 2023-10-30.
CIK 0001389512
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $49K since 2014, against 87 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLFS | 347,085 | $13.4M |
Shares reported on the most recent Form 4, priced at the 2023-11-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLFS | SELL · 10b5-1 | 2023-10-30 | 2023-11-01 | $9.13 | $1.3M | +4.4% | +28.3% | +68.0% |
| BLFS | SELL · 10b5-1 | 2023-09-28 | 2023-10-02 | $14.16 | $12K | -10.2% | -23.2% | +20.0% |
| BLFS | SELL · 10b5-1 | 2023-08-25 | 2023-08-29 | $10.99 | $19K | +9.6% | +11.9% | +7.0% |
| BLFS | SELL · 10b5-1 | 2023-08-14 | 2023-08-16 | $12.38 | $3K | -4.5% | +11.0% | +2.7% |
| BLFS | SELL · 10b5-1 | 2023-06-27 | 2023-06-29 | $22.91 | $20K | +0.0% | -13.0% | -38.5% |
| BLFS | SELL · 10b5-1 | 2023-05-31 | 2023-06-02 | $23.21 | $39K | +1.4% | -6.1% | -42.3% |
| BLFS | SELL · 10b5-1 | 2023-05-15 | 2023-05-17 | $21.03 | $1.4M | +6.8% | +8.0% | -43.9% |
| BLFS | SELL | 2023-04-06 | 2023-05-16 | $20.03 | $129K | +10.6% | +12.1% | -38.1% |
| BLFS | SELL | 2023-03-29 | 2023-03-31 | $20.62 | $19K | -0.9% | -16.1% | +4.7% |
| BLFS | SELL | 2023-03-07 | 2023-03-09 | $22.95 | $13K | -1.5% | -12.4% | +5.4% |
| BLFS | SELL | 2023-03-01 | 2023-03-03 | $22.75 | $195K | -10.4% | -16.1% | -3.7% |
| BLFS | SELL | 2023-02-09 | 2023-02-13 | $24.60 | $4K | +0.8% | -4.7% | -13.7% |
| BLFS | SELL | 2022-12-28 | 2022-12-30 | $16.90 | $15K | +25.8% | +23.9% | +11.4% |
| BLFS | SELL | 2022-11-29 | 2022-11-30 | $19.93 | $19K | -6.7% | -13.9% | +10.1% |
| BLFS | SELL | 2022-11-10 | 2022-11-14 | $23.16 | $4K | -11.4% | -19.0% | -4.5% |
| BLFS | SELL | 2022-09-29 | 2022-09-30 | $23.02 | $19K | -9.2% | +3.5% | -20.2% |
| BLFS | SELL | 2022-08-31 | 2022-09-01 | $23.44 | $21K | +9.4% | -7.1% | -11.3% |
| BLFS | SELL | 2022-08-10 | 2022-08-11 | $23.17 | $4K | -6.3% | +11.5% | -27.2% |
| BLFS | SELL | 2022-06-28 | 2022-06-30 | $14.86 | $13K | +15.5% | +41.1% | +73.6% |
| BLFS | SELL | 2022-05-27 | 2022-06-01 | $14.53 | $11K | -0.8% | +11.0% | +78.1% |
| BLFS | SELL | 2022-05-13 | 2022-05-17 | $12.32 | $2K | +17.8% | +6.1% | +108.1% |
| BLFS | SELL | 2022-04-18 | 2022-04-19 | $17.59 | $429K | -24.5% | -27.9% | -3.7% |
| BLFS | SELL | 2022-04-11 | 2022-04-13 | $19.31 | $386K | -28.6% | -32.8% | -16.1% |
| BLFS | SELL | 2022-03-29 | 2022-03-31 | $22.24 | $18K | -16.8% | -41.9% | -35.8% |
| BLFS | SELL | 2022-03-07 | 2022-03-09 | $23.81 | $476K | -3.9% | -15.4% | -38.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.